Krishi-Mitra Biotech Research Center Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.58 M
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit -19152.09%
(FY 2023)
- Ebitda -312.59%
(FY 2023)
- Net Worth -768.47%
(FY 2023)
- Total Assets -48.27%
(FY 2023)
About Krishi-Mitra Biotech Research Center
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.58 M.
Ganesh Chandak and Govind Chandak serve as directors at the Company.
- CIN/LLPIN
U01403MH2012PTC229573
- Company No.
229573
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Wardha, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Krishi-Mitra Biotech Research Center?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govind Chandak  | Managing Director | 13-Apr-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Chandak | Director | 26-Apr-2017 | Current |
Financial Performance of Krishi-Mitra Biotech Research Center.
Krishi-Mitra Biotech Research Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 19152.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 768.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krishi-Mitra Biotech Research Center?
In 2023, Krishi-Mitra Biotech Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Ramdevbaba Varco Developers India Private LimitedActive 15 years 1 monthGanesh Chandak and Govind Chandak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 31 Oct 2012 | ₹9.58 M | Open |
How Many Employees Work at Krishi-Mitra Biotech Research Center?
Unlock and access historical data on people associated with Krishi-Mitra Biotech Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krishi-Mitra Biotech Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krishi-Mitra Biotech Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
